Maha Katabi
Insider Reports History
- Location
- Menlo Park, CA
- Signature
- /s/ Joseph R. Young, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Maha Katabi:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aerovate Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 12,500 | $204,625 | $16.37 | 05 Jun 2024 | Direct |
| RayzeBio, Inc. | Director | Common Stock | 0 | $0 | $62.50 | 26 Feb 2024 | Indirect |
| Vera Therapeutics, Inc. | Director | Stock Option (right to buy) | 14,000 | 14 May 2025 | Direct | ||
| RayzeBio, Inc. | Director | Series D Convertible Preferred Stock | 0 | 19 Sep 2023 | By Sofinnova Venture Partners XI, L.P. | ||
| RayzeBio, Inc. | Director | Series D Convertible Preferred Stock | 0 | 19 Sep 2023 | By Sofinnova Venture Partners X, L.P. | ||
| RayzeBio, Inc. | Director | Stock Option (right to buy) | 0 | 26 Feb 2024 | Direct |
Insider Reports Filed by Maha Katabi
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | 14 May 2025 | 1 | $0 | 4 | Director | 16 May 2025, 16:13 |
| JBIO | Aerovate Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director, 10%+ Owner | 07 Jun 2024, 18:00 |
| VERA | Vera Therapeutics, Inc. | 15 May 2024 | 1 | $0 | 4 | Director | 17 May 2024, 16:13 |
| VERA | Vera Therapeutics, Inc. | 21 Mar 2024 | 6 | -$34,099,583 | 4 | Director | 25 Mar 2024, 21:46 |
| /report/000141588924005511-katabi-maha-2024-02-26 | RayzeBio, Inc. | 26 Feb 2024 | 3 | -$151,220,500 | 4 | Director | 27 Feb 2024, 16:47 |
| VERA | Vera Therapeutics, Inc. | 30 Jan 2024 | 1 | +$4,999,990 | 4 | Director | 01 Feb 2024, 17:58 |
| JBIO | Aerovate Therapeutics, Inc. | 02 Jan 2024 | 1 | +$47,471 | 4 | Director, 10%+ Owner | 04 Jan 2024, 18:00 |
| /report/000162828023039536-katabi-maha-2023-11-17 | RayzeBio, Inc. | 17 Nov 2023 | 1 | $0 | 4 | Director | 17 Nov 2023, 18:37 |
| /report/000120919123050305-katabi-maha-2023-09-19 | RayzeBio, Inc. | 19 Sep 2023 | 6 | +$8,499,996 | 4 | Director | 21 Sep 2023, 17:10 |
| /report/000120919123049504-katabi-maha-2023-09-14 | RayzeBio, Inc. | 14 Sep 2023 | 0 | $0 | 3 | Director | 14 Sep 2023, 19:27 |
| JBIO | Aerovate Therapeutics, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 08 Jun 2023, 18:00 |
| VERA | Vera Therapeutics, Inc. | 10 May 2023 | 1 | $0 | 4 | Director | 12 May 2023, 16:14 |
| JBIO | Aerovate Therapeutics, Inc. | 03 Jan 2023 | 1 | +$47,496 | 4 | Director, 10%+ Owner | 05 Jan 2023, 16:00 |
| JBIO | Aerovate Therapeutics, Inc. | 21 Jun 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 22 Jun 2022, 17:00 |
| VERA | Vera Therapeutics, Inc. | 24 May 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 26 May 2022, 16:11 |
| JBIO | Aerovate Therapeutics, Inc. | 03 Jan 2022 | 1 | +$47,494 | 4 | Director, 10%+ Owner | 05 Jan 2022, 16:15 |
| JBIO | Aerovate Therapeutics, Inc. | 01 Jul 2021 | 4 | +$5,027,488 | 4 | Director, 10%+ Owner | 06 Jul 2021, 16:27 |
| JBIO | Aerovate Therapeutics, Inc. | 29 Jun 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 29 Jun 2021, 19:42 |
| VERA | Vera Therapeutics, Inc. | 18 May 2021 | 3 | +$7,999,992 | 4 | Director, 10%+ Owner | 18 May 2021, 20:17 |
| VERA | Vera Therapeutics, Inc. | 13 May 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 17 May 2021, 20:40 |
| VERA | Vera Therapeutics, Inc. | 13 May 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 13 May 2021, 19:21 |
| JBIO | Aerovate Therapeutics, Inc. | 01 Feb 2021 | 3 | +$17,503,441 | 4 | Director, 10%+ Owner | 01 Jul 2021, 18:34 |